过去一年中添加的文章，按日期排序
Comparing Apixaban with Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices
C Soares, Y Desai, E Sorensen, L Dees… - American Journal of …, 2024 - ajconline.org
10 天前 - … with long-term warfarin anticoagulation to prevent thrombotic complications(1).
Direct oral anticoagulants (DOACs) are easier to manage than warfarin for other medical …
Direct oral anticoagulants (DOACs) are easier to manage than warfarin for other medical …
[引用][C] A COMPARATIVE EFFECTIVENESS STUDY ON THE SAFETY OF UNINTERRUPTED ANTICOAGULATION IN THE SETTING OF ROUTINE COLONOSCOPY
A Giap, I Hang, HA Huynh, Q Chen, B Wu… - Gastrointestinal …, 2024 - giejournal.org
19 天前 - … A comparative effectiveness study was conducted on patients aged 45-75 taking
warfarin or direct oral anticoagulant, who underwent outpatient elective colonoscopy in a large …
warfarin or direct oral anticoagulant, who underwent outpatient elective colonoscopy in a large …
Direct Comparison of the Effectiveness and Safety Among Direct Oral Anticoagulants and Warfarin in Japanese Patients: Nationwide Cohort Study in Japan
S Katayama, Y Aoki, A Akita, R Satake… - Clinical Pharmacology …, 2024 - Wiley Online Library
20 天前 - … Direct oral anticoagulant drugs (DOACs) are available in addition to warfarin for
the … Recently, direct oral anticoagulant drugs (DOACs), with mechanisms unlike those of …
the … Recently, direct oral anticoagulant drugs (DOACs), with mechanisms unlike those of …
[引用][C] Patient perspectives on evidence supporting drug safety and effectiveness:“What does it mean for me?”
21 天前 - … As a case study, we used direct oral anticoagulants (DOACs), a therapeutic class
in which early RCTs showed improvements in stroke rates compared with warfarin. However, …
in which early RCTs showed improvements in stroke rates compared with warfarin. However, …
Apixaban versus warfarin for primary thromboprophylaxis in patients with multiple myeloma undergoing immunomodulatory treatment.
21 天前 - … -dose direct oral anticoagulants as an alternative to warfarin … comparing these two
therapies are limited. We aim to compare the efficacy and safety of apixaban versus warfarin …
therapies are limited. We aim to compare the efficacy and safety of apixaban versus warfarin …
38 A meta-analysis of randomised controlled trials comparing direct oral anticoagulants against warfarin for the treatment left ventricular thrombus
S Khalid, T Joseph, JM Blaxill, AM Mozid… - 2024 - heart.bmj.com
26 天前 - … (1), with warfarin being the mainstay treatment. Off-label use of direct oral anticoagulants
(… Previously meta-analyses comparing DOACs against warfarin for the treatment LVT …
(… Previously meta-analyses comparing DOACs against warfarin for the treatment LVT …
# 1923 Anticoagulation and risk of stroke in patients with incident atrial fibrillation and CKD stages 4-5—results from the nationwide FinACAF study
H Jyrkilä, K Kaartinen, L Martola… - Nephrology Dialysis …, 2024 - academic.oup.com
28 天前 - … limited number of patients with direct oral anticoagulation (DOAC) exposure exceeding
730 days. Hazard ratios [95% confidence intervals (CI)] comparing different OACs or no …
730 days. Hazard ratios [95% confidence intervals (CI)] comparing different OACs or no …
Preventing Strokes in Anticoagulated Patients With Breakthrough Events: Will LAAO Triumph Where OAC Falls Short?
29 天前 - … ) but do not provide absolute protection; some patients may … trials of all 4 direct oral
anticoagulants, the annualized rate … on direct oral anticoagulants and warfarin, respectively. …
anticoagulants, the annualized rate … on direct oral anticoagulants and warfarin, respectively. …
Direct oral anticoagulants vs Vitamin-K antagonists in solid organ transplant recipients: A systematic review and meta-analysis
C He, C Yao - Pakistan Journal of Medical Sciences, 2024 - pjms.org.pk
29 天前 - … Objective: Oure review aimed to examine evidence on the safety and efficacy of
direct oral anticoagulants (DOAC) vs Vitamin K antagonists (VKA) in patients with solid organ …
direct oral anticoagulants (DOAC) vs Vitamin K antagonists (VKA) in patients with solid organ …
Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis
Y Zhang, J Wang, N Shen, J Jiang, Y Xie - Renal Failure, 2024 - Taylor & Francis
30 天前 - … Databases were searched using various combinations of ‘direct oral anticoagulants’,
‘DOAC’, ‘novel oral anticoagulants’, ‘NOAC’, ‘apixaban’, ‘warfarin’, ‘Vitamin K antagonist’, ‘…
‘DOAC’, ‘novel oral anticoagulants’, ‘NOAC’, ‘apixaban’, ‘warfarin’, ‘Vitamin K antagonist’, ‘…